Skip to main navigation

Home
News & Events
Financial Information
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Governance
IR Resources

Media News

Tackling Uncertainty In Drug R&D

Source

Life Science Leader

Disease Cancelling Technology Emulates Sound Cancelling Technology to Mute Cancer

Source

Genetic Engineering & Biotechnology News

Disease-cancelling drugs: Immuneering raises $62m in Series B round

Source

Pharmaceutical Technology

Immuneering secures $62M series B to advance tech-driven pipeline

Source

BioWorld

Biomarkers Show the Power of Contextualization

Source

Genetic Engineering & Biotechnology News

Silencing gene expression to cure complex diseases

Source

Massachusetts Institute of Technology

Immuneering CEO Aims to Identify 90 Drug Programs Within Five Years

Source

BioSpace

The Bio Report: Reversing Disease Signals

Source

SoundCloud

Print Page

Email Alerts

Email Page

RSS Feeds

Site - Footer Menu

ABOUT
PLATFORM
PIPELINE
NEWSROOM
PUBLICATIONS
CONTACT

Connect with us on social media.

Linkedin Twitter

© Immuneering Corporation 2022

Site - Footer Bottom

Terms of Use
Privacy Policy